POMT1 Gene Limb-girdle muscular dystrophy, autosomal recessive type 2N NGS Genetic Test
Short Name: POMT1 LGMD2N NGS Test
Also known as: POMT1 Gene Sequencing, LGMD2N Genetic Test, POMT1 Mutation Analysis (NGS)
POMT1 Gene Limb-girdle muscular dystrophy, autosomal recessive type 2N NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS) on Blood / Extracted DNA / FTA Card Blood Spot samples. Results in Reports are delivered within 3 to 4 weeks after sample receipt.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr SULOCHANA HEMCHANDRA HOLLA
Consultant Medical Geneticist · Reg: 8532
Last updated: September 7, 2026
Overview
The purpose of this test is to identify disease-causing variants in the POMT1 gene that are associated with autosomal recessive limb-girdle muscular dystrophy type 2N (LGMD2N). This test provides a definitive molecular diagnosis and assists in early management, genetic counseling, and reproductive planning. NGS genetic DNA test detecets for variant and mutation detection in POMT1 gene for Limb-girdle muscular dystrophy, autosomal recessive type 2N
- Test Code
- 4210
- Price
- ₹20,000
- Sample Type
- Blood / Extracted DNA / FTA Card Blood Spot
- Result Time
- Reports are delivered within 3 to 4 weeks after sample receipt.
- Fasting Required
- No
- Method
- Next Generation Sequencing (NGS)
Muscular dystrophy is a group of inherited genetic disorders that cause muscle weakness and degeneration. Limb-girdle muscular dystrophy (LGMD) is a type of muscular dystrophy that primarily affects the muscles around the hips and shoulders. Autosomal recessive LGMD type 2N is caused by mutations in the POMT1 gene.
Symptoms of LGMD Autosomal Recessive Type 2N
The symptoms of LGMD autosomal recessive type 2N usually appear during childhood or adolescence. The initial symptoms may include difficulty in walking, running, and climbing stairs. As the disease progresses, muscle weakness and wasting spread to other parts of the body, including the arms, legs, and trunk. Patients may also experience joint stiffness, contractures, and respiratory problems.
Diagnosis of LGMD Autosomal Recessive Type 2N
The diagnosis of LGMD autosomal recessive type 2N involves a combination of clinical examination, genetic testing, and muscle biopsy. The physician may perform a physical examination to assess muscle strength, tone, and reflexes. Genetic testing can identify mutations in the POMT1 gene that cause the disease. A muscle biopsy involves removing a small sample of muscle tissue and examining it under a microscope to detect any abnormalities.
NGS Genetic DNA Test for LGMD Autosomal Recessive Type 2N
Next-generation sequencing (NGS) genetic DNA testing is a powerful tool for identifying mutations in the POMT1 gene that cause LGMD autosomal recessive type 2N. This test involves sequencing the entire DNA sequence of the POMT1 gene to identify any mutations that may be present. NGS genetic DNA testing is a highly accurate and sensitive method for detecting genetic mutations, and it can provide a definitive diagnosis for patients with LGMD autosomal recessive type 2N.
Cost of NGS Genetic DNA Test for LGMD Autosomal Recessive Type 2N in India
The cost of NGS genetic DNA testing for LGMD autosomal recessive type 2N in India is approximately INR 20,000. This cost may vary depending on the specific laboratory that performs the test and any additional services that may be required. Patients should consult with their physician or genetic counselor to determine the most appropriate testing options and costs for their individual needs.
Conclusion
LGMD autosomal recessive type 2N is a rare genetic disorder that can cause significant muscle weakness and degeneration. NGS genetic DNA testing is a powerful tool for identifying mutations in the POMT1 gene that cause the disease, and it can provide a definitive diagnosis for patients. The cost of NGS genetic DNA testing for LGMD autosomal recessive type 2N in India is approximately INR 20,000. Patients should consult with their physician or genetic counselor to determine the most appropriate testing options and costs for their individual needs.
DNA Labs India provides NGS genetic DNA testing for LGMD autosomal recessive type 2N and other genetic disorders. Contact us today to learn more about our testing services and how we can help you achieve a definitive diagnosis.
Sample Collection
No special preparation is required. Please carry any previous medical records, MRI/EMG reports, muscle biopsy reports, and family history details. Pre-test genetic counseling is provided.
Method: Venipuncture / Blood spot on FTA card / DNA extraction
Laboratory Analysis
A trained phlebotomist will collect a venous blood sample. If using FTA card, a drop of blood will be placed on the card and dried.
Report Delivery
You can return to routine activities immediately. There are no dietary restrictions. The report will be shared online and via email/WhatsApp in 3-4 weeks.
Timeline: Reports are delivered within 3 to 4 weeks after sample receipt.
Patient Instructions
About This Test
Who Should Get This Test
The purpose of this test is to identify disease-causing variants in the POMT1 gene that are associated with autosomal recessive limb-girdle muscular dystrophy type 2N (LGMD2N). This test provides a definitive molecular diagnosis and assists in early management, genetic counseling, and reproductive planning.
NGS genetic DNA test detecets for variant and mutation detection in POMT1 gene for Limb-girdle muscular dystrophy, autosomal recessive type 2N
How to Prepare
- No special preparation required.
- Fasting is not required.
- Inform us if you have had a blood transfusion or bone marrow transplant.
Doctor's Notes
Reviewed by Dr SULOCHANA HEMCHANDRA HOLLA — MBBS, MD (Medical Genetics) · Reg. No. 8532
"Patients with suggestive LGMD symptoms and elevated creatine kinase should undergo genetic testing after careful clinical evaluation. A definitive molecular diagnosis in POMT1 is essential for accurate genetic counseling and management."
Last updated: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Hemolyzed or clotted blood sample
- Incorrect anticoagulant (e.g., heparin)
- Insufficient blood volume or DNA quantity
- Improper labeling or sample leakage
- FTA card not dried properly
Understanding Your Results
If you have symptoms such as progressive muscle weakness in the hip and shoulder girdles, difficulty walking, climbing stairs, frequent falls, or elevated creatine kinase, consult a neurologist. If you have a family history of LGMD, discuss genetic testing with a clinical geneticist.
Limitations
- ⚠NGS-based POMT1 sequencing may not detect large exon-level deletions/duplications unless MLPA or CNV analysis is specifically performed.
- ⚠Variants of uncertain clinical significance (VUS) may be reported; segregation and functional studies are sometimes required.
- ⚠Repeat expansions and deep intronic variants may not be detected by this NGS test.
- ⚠Results should be interpreted by a clinical geneticist in the context of the patient's phenotype and family history.
Risks & Considerations
- ●Minimal pain or bruising at the blood draw site
- ●Lightheadedness or fainting during blood collection
- ●Very rare risk of infection or bleeding
Interfering Factors
- ●Prior allogeneic bone marrow transplant leading to mixed donor-recipient DNA
- ●Insufficient DNA quantity or highly degraded DNA
- ●Maternal cell contamination in cord blood samples
- ●Sample mix-up or mislabeling
Frequently Asked Questions
What is LGMD2N?
Which gene is tested in this NGS test?
What type of samples can be used for this test?
Do I need to fast before the POMT1 NGS test?
How long does the POMT1 NGS genetic test take to complete?
What is the cost of the POMT1 LGMD2N NGS test in India?
Will this test detect all types of limb-girdle muscular dystrophy?
Is home sample collection available?
Is genetic counseling included in the test?
What does a 'variant of uncertain significance' result mean?
Can this test confirm a diagnosis of LGMD2N?
Will insurance cover this genetic test?
Related Tests
Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.